Indication

For the treatment of severe thrombocytopenia in adult patients with chronic liver disease undergoing invasive procedures.

Medicine details

Medicine name:
lusutrombopag (Mulpleo)
SMC ID:
SMC2227
Pharmaceutical company
Shionogi Limited
BNF chapter
Nutrition and blood
Submission type
Full
Status
Publication due date:
09 December 2019
SMC meeting date:
05 November 2019
Patient group submission deadline:
30 September 2019